Skip to main content

Table 1 Patients and tumor characteristics

From: ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma

Parameters

Value

Number of patients

120

Number of males (%)

83 (70%)

Median age at surgery (years) (IQR)

56 (50–65)

Median follow-up (months) (IQR)

92.5 (62.3–99.4)

Median tumor size (cm) (IQR)

5.0 (3.5–7.0)

Symptoms on first diagnosis (%)

47 (40%)

Tumor stage (TNM2009)

 

 pT1a

37(30.8%)

 pT1b

55 (45.8%)

 pT2

18 (15%)

 pT3

10 (8.3%)

Regional lymph node metastasis (TNM 2009) (%)

3 (2.5%)

Distant metastasis on first diagnosis (TNM 2009) (%)

19 (16%)

Fuhrman grade

 

 1

18 (15%)

 2

70 (58.3%)

 3

25 (20.8%)

 4

7 (5.8%)

Type of surgery (%)

 

 Radical Nephrectomy

114 (95%)

 Partial Nephrectomy

6 (5%)

ABCG2 (%)

 

 (−)

57 (48%)

 (+)

52 (43%)

 (++)

11 (9.2%)